Broncus Holding Corporation (HKG:2216)
Hong Kong · Delayed Price · Currency is HKD 0.7450
+0.0100 (1.36%)
Oct 2, 2026, 3:15 PM HKT
Broncus Holding Revenue
Broncus Holding had revenue of $3.29M USD in the half year ending June 30, 2026, a decrease of -11.23%. This brings the company's revenue in the last twelve months to $1.81M, down -70.23% year-over-year. In the year 2025, Broncus Holding had annual revenue of $174.00K, down -97.86%.
Revenue (ttm)
$1.81M
Revenue Growth
-70.23%
P/S Ratio
27.66
Revenue / Employee
$9.28K
Employees
195
Market Cap
392.67M HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 174.00K | -7.96M | -97.86% |
| Dec 31, 2024 | 8.13M | -2.12M | -20.71% |
| Dec 31, 2023 | 10.26M | 842.00K | 8.95% |
| Dec 31, 2022 | 9.41M | -1.48M | -13.57% |
| Dec 31, 2021 | 10.89M | 7.63M | 234.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sisram Medical | 2.91B |
| Austar Lifesciences | 1.86B |
| Yestar Healthcare Holdings Company | 1.56B |
| Gaush Meditech | 1.53B |
| Vincent Medical Holdings | 964.90M |
| Acotec Scientific Holdings | 721.55M |
| MicroPort CardioFlow Medtech | 444.00M |
| Suzhou Basecare Medical Corporation | 300.95M |